Difference between revisions of "Profiles"
Jump to navigation
Jump to search
Line 17: | Line 17: | ||
*[[Media:QIBADWIProfilev1.45_20170427_v5_accepted_linenumbers.pdf| DWI Profile 2017-04-27]] ''Open until July 28, 2017'' | *[[Media:QIBADWIProfilev1.45_20170427_v5_accepted_linenumbers.pdf| DWI Profile 2017-04-27]] ''Open until July 28, 2017'' | ||
*[[Media:QIBA_AmyloidPET_15June2017.pdf| QIBA PET Amyloid Profile 2017-06-15]] ''Open until September 15, 2017'' | *[[Media:QIBA_AmyloidPET_15June2017.pdf| QIBA PET Amyloid Profile 2017-06-15]] ''Open until September 15, 2017'' | ||
− | *[[Media:QIBA_fMRI_Profile_1_PC.pdf| QIBA fMRI Profile 2017-06-19]] ''Open until September 19, 2017'' | + | *[[Media:QIBA_fMRI_Profile_1_PC-rev1.pdf| QIBA fMRI Profile 2017-06-19]] ''Open until September 19, 2017'' |
Public Comment closed. | Public Comment closed. |
Revision as of 21:17, 28 June 2017
Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.
Stage 3: Technically Confirmed Profiles
Stage 2: Consensus Profiles
Stage 1: Public Comment Profiles
Open for Public Comment. Submit comments here: http://tinyurl.com/QIBA-Public-Comment-Form
- DWI Profile 2017-04-27 Open until July 28, 2017
- QIBA PET Amyloid Profile 2017-06-15 Open until September 15, 2017
- QIBA fMRI Profile 2017-06-19 Open until September 19, 2017
Public Comment closed.
- QIBA Profile: QIBA Profile: Lung Nodule Volume Assessment and Monitoring in Low Dose CT Screening, June 1, 2016 (Closed Sept 2016)
- DCE-MRI Quantification 2011-12-13 (Closed Feb 2012)
Statements of Endorsement
See Also
- How to use QIBA Profiles
- Biomarker Committee pages may also have links to DRAFT Profile documents for the next Stage.
- Profile Conformance describes how sites and products claim conformance to a Profile.
- QIBA Profile Template shows the structure, rationale and content of a Profile (show "All Markup" to see guidance in the Word comments)